IBEX Limited Announces Record Fourth Quarter and Fiscal Year 2020 Financial Results
Fiscal Year 2020
- Revenue increased 10% year-over-year to
$405.1 million - Net income from continuing operations increased to
$7.8 million - Adjusted EBITDA increased 49% year-over-year to
$54.1 million - Strong net cash flow from operating activities of
$51.7 million
Q4 Fiscal 2020
- Revenue increased 14.7% year-over-year to
$100.9 million - Net loss from continuing operations decreased to
$3.8 million - Adjusted EBITDA increased 83% to
$13.5 million
“Fiscal year 2020 was a milestone year for ibex–delivering record revenues surpassing
Fiscal Year 2020 Financial Highlights:
Revenue
- Revenue increased 10% to
$405.1 million , compared to$368.4 million in the prior year.
Net Income / (Loss) From Continuing Operations
- Net income from continuing operations increased to
$7.8 million , compared to a net loss from continuing operations of$4.5 million in the prior year. - Net income / (loss) from continuing operations margin increased to 1.9%, compared to (1.2)% in the prior year.
- Non-GAAP adjusted net income from continuing operations increased to
$15.6 million , compared to$1.8 million in the prior year.
Adjusted EBITDA
- Non-GAAP adjusted EBITDA from continuing operations increased to
$54.1 million , compared to$36.3 million in the prior year. - Non-GAAP adjusted EBITDA from continuing operations margin increased to 13.4%, compared to 9.9% in the prior year.
Earnings Per Share
- IFRS fully diluted earnings per share was
$0.00 in fiscal years 2020 and 2019.* - Non-GAAP pro forma adjusted earnings per share increased to
$0.84 , compared to$0.10 in the prior year.
Cash Flow, Balance Sheet, and Capital Expenditures
- Cash flow from operations increased to
$51.7 million , compared to$2.2 million in the prior year. - Non-GAAP free cash flow increased to
$25.6 million , compared to an outflow of$2.5 million in the prior year. - Non-GAAP net debt decreased to
$84.1 million , compared to$109.4 million in the prior year. - Capital expenditures were
$16.9 million , or 4.2% of revenue, compared to$9.7 million , or 2.6% of prior year revenue.
Fourth Quarter 2020 Financial Highlights:
Revenue
- Revenue of
$100.9 million was minimally impacted by COVID-19, and increased 14.7% compared to the prior year quarter.
Net Income / (Loss) From Continuing Operations
- Net loss from continuing operations decreased to
$3.8 million , compared to a net loss from continuing operations of$4.6 million in the prior year quarter. - Net loss from continuing operations margin decreased to (3.8)%, compared to (5.3)% in the prior year quarter.
- Non-GAAP adjusted net income from continuing operations increased to
$2.6 million , compared to a non-GAAP adjusted net loss from continuing operations of$1.4 million in the prior year quarter.
Adjusted EBITDA
- Non-GAAP adjusted EBITDA from continuing operations increased to
$13.5 million , compared to$7.4 million in the prior year quarter. - Non-GAAP adjusted EBITDA from continuing operations margin increased to 13.4%, compared to 8.4% in the prior year quarter.
Earnings Per Share
- IFRS fully diluted earnings per share was
$0.00 in the fourth quarter of fiscal years 2020 and 2019.* - Non-GAAP pro forma adjusted earnings per share increased to
$0.14 , compared to ($0.07 ) in the prior year quarter.
* IFRS fully diluted earnings per share does not reflect the recapitalization that occurred in connection with ibex’s initial public offering.
Fiscal Year 2020 Business Highlights:
- Added 24 new customer logos
- Top three client concentration decreased to 43.7% from 50.6% in the prior year
- Launched the Wave X Purpose Built Technology Suite enabling highly customized CX solutions
- Digital business increased to 30% of our overall revenue to
$119.6 million - New Economy revenue increased by 35% compared to prior year
- Non-voice revenue increased by 42% compared to prior year
- Increased our nearshore and offshore footprint by opening three new sites and adding 1,730 workstations in
the Philippines and 843 in nearshore sites, boosting our non-US capacity by 35% over prior year - Expanded our digital marketing and on-line customer acquisition solutions by adding the Healthcare, Financial Services and Utility industries to our portfolio
2021 Business Outlook
Conference Call and Webcast Information
An audio replay of the call will also be available to investors beginning at approximately
Financial Information
While the financial figures included in this press release have been computed in accordance with International Financial Reporting Standards (“IFRS”) as issued by the
Non-GAAP Financial Measures
We provide non-GAAP financial measures in addition to reported IFRS results prepared in accordance with IFRS. Management believes these measures help illustrate underlying trends in ibex's business and uses the non-GAAP financial measures to establish budgets and operational goals, for managing ibex's business and evaluating its performance. We anticipate that we will continue to report both IFRS and certain non-GAAP financial measures in our financial results. Because ibex's non-GAAP financial measures are not calculated according to IFRS, these measures are not comparable to IFRS and may not necessarily be comparable to similarly described non-GAAP measures reported by other companies within ibex's industry. Consequently, our non-GAAP financial measures should not be evaluated in isolation or replace comparable IFRS measures, but, rather, should be considered together with our unaudited consolidated statements of financial position, unaudited consolidated statements of profit or loss and other comprehensive income, and unaudited consolidated statements of cash flows presented herein and prepared in accordance with IFRS issued by IASB.
In this earnings release, we are introducing “adjusted net income / (loss) from continuing operations,” which we define as net income / (loss) from continuing operations before the effect of the following items: non-recurring expenses (including litigation and settlement expenses, costs related to COVID-19, and expenses related to our initial public offering), impairment, other income, fair value adjustment related to the Amazon warrant, share-based payments, and foreign exchange gains or losses. We believe these items are not reflective of our long-term performance. We use adjusted net income / (loss) from continuing operations internally to understand what we believe to be the recurring nature of our net income / (loss) from continuing operations and as a basis to calculate a pro forma adjusted earnings per share now that our initial public offering has been consummated. We also believe that adjusted net income / (loss) from continuing operations is widely used by investors, securities analysts and other interested parties as a supplemental measure of profitability.
ibex is not providing a quantitative reconciliation of forward-looking non-GAAP adjusted EBITDA from continuing operations to the most directly comparable IFRS measure because it is unable to predict with reasonable certainty the ultimate outcome of certain significant items without unreasonable effort. These items include, but are not limited to, non-recurring expenses, fair value adjustments, share-based compensation expense, and impairment of assets. These items are uncertain, depend on various factors, and could have a material impact on IFRS reported results for the guidance period.
About ibex
ibex helps the world’s preeminent brands more effectively engage their customers with services ranging from customer support, technical support, inbound/outbound sales, business intelligence and analytics, digital demand generation, and CX surveys and feedback analytics.
Forward Looking Statements
In addition to historical information, this release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. These statements include, but are not limited to, statements regarding our future financial and operating performance, including our outlook and guidance, and our strategies, priorities and business plans. Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Factors that could impact our actual results include: developments relating to COVID-19; the Frontier restructuring and its proceedings under Chapter 11 of the United States Bankruptcy Code; our ability to attract new business and retain key clients; our ability to enter into multi-year contracts with our clients at appropriate rates; the potential for our clients or potential clients to consolidate; our clients deciding to enter into or further expand their insourcing activities; our ability to operate as an integrated company under the IBEX brand; our ability to manage portions of our business that have long sales cycles and long implementation cycles that require significant resources and working capital; our ability to manage our international operations, particularly in
Media Contact:
IR Contact: Brinlea Johnson,
Unaudited Consolidated Statements of Financial Position
US$ in thousands | ||||||||
Assets | ||||||||
Non-current assets | ||||||||
$ | 11,832 | $ | 11,832 | |||||
Other intangible assets | 2,781 | 2,928 | ||||||
Property and equipment | 84,588 | 82,309 | ||||||
Investment in joint venture | 331 | 227 | ||||||
Deferred tax asset | 2,223 | 2,517 | ||||||
Warrant asset | 2,611 | 3,316 | ||||||
Other assets | 4,834 | 3,398 | ||||||
Total non-current assets | $ | 109,200 | $ | 106,527 | ||||
Current assets | ||||||||
Trade and other receivables | 62,579 | 71,134 | ||||||
Due from related parties | 1,587 | 1,768 | ||||||
Cash and cash equivalents | 21,870 | 8,873 | ||||||
Total current assets | $ | 86,036 | $ | 81,775 | ||||
Total assets | $ | 195,236 | $ | 188,302 | ||||
Equity and liabilities | ||||||||
Equity attributable to owners of the parent | ||||||||
Share capital | $ | 12 | $ | 12 | ||||
Additional paid-in capital | 96,207 | 96,207 | ||||||
Other reserves | 29,456 | 29,585 | ||||||
Accumulated deficit | (109,527 | ) | (117,176 | ) | ||||
Total equity | $ | 16,148 | $ | 8,628 | ||||
Non-current liabilities | ||||||||
Deferred revenue | $ | 434 | $ | 753 | ||||
Lease liabilities | 62,044 | 58,602 | ||||||
Borrowings | 3,782 | 7,184 | ||||||
Deferred tax liability | 117 | 147 | ||||||
Other non-current liabilities | 7,058 | 1,607 | ||||||
Total non-current liabilities | $ | 73,435 | $ | 68,293 | ||||
Current liabilities | ||||||||
Trade and other payables | $ | 53,213 | $ | 46,890 | ||||
Income tax payables | 3,087 | 1,467 | ||||||
Lease liabilities | 12,668 | 10,632 | ||||||
Borrowings | 27,476 | 41,835 | ||||||
Deferred revenue | 3,470 | 4,388 | ||||||
Due to related parties | 5,739 | 6,169 | ||||||
Total current liabilities | $ | 105,653 | $ | 111,381 | ||||
Total liabilities | $ | 179,088 | $ | 179,674 | ||||
Total equity and liabilities | $ | 195,236 | $ | 188,302 | ||||
Unaudited Consolidated Statements of Profit or Loss and Other Comprehensive Income
Quarter ended | Year ended | ||||||||||||||
US$ in thousands | |||||||||||||||
Revenue | $ | 100,880 | $ | 87,915 | $ | 405,135 | $ | 368,380 | |||||||
Payroll and related costs | 69,009 | 63,098 | 276,255 | 254,592 | |||||||||||
Share-based payments | 478 | 48 | 359 | 4,087 | |||||||||||
Reseller commission and lead expenses | 3,724 | 4,839 | 17,328 | 27,877 | |||||||||||
Depreciation and amortization | 6,012 | 5,203 | 24,472 | 20,895 | |||||||||||
Other operating costs | 22,391 | 17,004 | 67,208 | 54,124 | |||||||||||
Income / (loss) from operations | (734 | ) | (2,277 | ) | 19,513 | 6,805 | |||||||||
Finance expenses | (2,238 | ) | (2,251 | ) | (9,428 | ) | (7,709 | ) | |||||||
Income / (loss) before taxation | (2,972 | ) | (4,528 | ) | 10,085 | (904 | ) | ||||||||
Income tax expense | (833 | ) | (119 | ) | (2,315 | ) | (3,615 | ) | |||||||
Net income / (loss) from continuing operations | (3,805 | ) | (4,647 | ) | 7,770 | (4,519 | ) | ||||||||
Net income on discontinued operation, net of tax | - | 8,568 | - | 15,484 | |||||||||||
Net income / (loss) for the year | (3,805 | ) | 3,921 | 7,770 | 10,965 | ||||||||||
Other comprehensive income / (loss) | |||||||||||||||
Item that will not be subsequently reclassified to profit or loss | |||||||||||||||
Actuarial (loss) / gain on retirement benefits | (184 | ) | 109 | (184 | ) | 109 | |||||||||
Item that will be subsequently reclassified to profit or loss | |||||||||||||||
Foreign currency translation adjustment | (211 | ) | (64 | ) | (248 | ) | (316 | ) | |||||||
Cash flow hedge - changes in fair value | (518 | ) | - | (518 | ) | - | |||||||||
(913 | ) | 45 | (950 | ) | (207 | ) | |||||||||
Total comprehensive income / (loss) | $ | (4,718 | ) | $ | 3,966 | $ | 6,820 | $ | 10,758 | ||||||
Loss per share from continuing operations attributable to the ordinary equity holders of the parent | |||||||||||||||
Basic loss per share | $ | - | $ | - | $ | - | $ | - | |||||||
Diluted loss per share | $ | (0.29 | ) | $ | (0.37 | ) | $ | - | $ | (0.36 | ) | ||||
Loss per share attributable to the ordinary equity holders of the parent | |||||||||||||||
Basic loss per share | $ | - | $ | - | $ | - | $ | - | |||||||
Diluted loss per share | $ | - | $ | - | $ | - | $ | - | |||||||
Unaudited Consolidated Statements of Cash Flows
Quarter ended | Year ended | ||||||||||||||
US$ in thousands | |||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES | |||||||||||||||
Income / (loss) before taxation | $ | (2,972 | ) | $ | 5,325 | $ | 10,085 | $ | 19,410 | ||||||
Adjustments for: | |||||||||||||||
Depreciation and amortization | 6,012 | 5,498 | 24,472 | 21,805 | |||||||||||
Amortization of warrant asset | 154 | 178 | 705 | 643 | |||||||||||
Foreign currency translation loss | (444 | ) | (602 | ) | (195 | ) | 78 | ||||||||
Share warrants | 2,506 | 1 | 3,138 | (364 | ) | ||||||||||
Phantom expense | 166 | 33 | (31 | ) | (300 | ) | |||||||||
Share-based payments | 312 | 30 | 390 | 5,262 | |||||||||||
Allowance of expected credit losses | 123 | 184 | 224 | 343 | |||||||||||
Share of profit from investment in joint venture | (119 | ) | (39 | ) | (533 | ) | (351 | ) | |||||||
(Gain) / loss on disposal of fixed assets | 63 | (99 | ) | (10 | ) | (140 | ) | ||||||||
Provision for defined benefit scheme | (13 | ) | 129 | 121 | 129 | ||||||||||
Impairment on intangibles | 777 | - | 777 | 163 | |||||||||||
Finance costs | 2,239 | 3,747 | 9,429 | 13,383 | |||||||||||
Decrease / (Increase) in trade and other receivables | 888 | (1,992 | ) | 9,042 | (18,019 | ) | |||||||||
Increase in renewal receivables | - | (15,290 | ) | - | (35,022 | ) | |||||||||
Increase in prepayments and other assets | (35 | ) | (167 | ) | (1,435 | ) | (173 | ) | |||||||
Increase in trade and other payables and other liabilities | 12,027 | 13,130 | 7,106 | 8,997 | |||||||||||
Cash generated from operations | 21,684 | 10,066 | 63,285 | 15,844 | |||||||||||
Interest paid | (2,239 | ) | (3,784 | ) | (9,429 | ) | (13,054 | ) | |||||||
Income taxes paid | (1,379 | ) | (260 | ) | (2,137 | ) | (588 | ) | |||||||
Net cash inflow from operating activities | $ | 18,066 | $ | 6,022 | $ | 51,719 | $ | 2,202 | |||||||
CASH FLOWS FROM INVESTING ACTIVITIES | |||||||||||||||
Purchase of property and equipment | $ | (264 | ) | $ | (2,910 | ) | $ | (4,283 | ) | $ | (5,612 | ) | |||
Purchase of other intangible assets | (497 | ) | (78 | ) | (982 | ) | (622 | ) | |||||||
Return on investment from joint venture | (309 | ) | - | - | 96 | ||||||||||
Proceed from sale of assets | - | 109 | - | 188 | |||||||||||
Cash adjustment from sale of subsidiary to parent company | - | (3,554 | ) | - | (3,554 | ) | |||||||||
Capital repayment from joint venture | 430 | 144 | 430 | 420 | |||||||||||
Net cash outflow from investing activities | $ | (640 | ) | $ | (6,289 | ) | $ | (4,835 | ) | $ | (9,084 | ) | |||
CASH FLOWS FROM FINANCING ACTIVITIES | |||||||||||||||
Proceeds from line of credit | $ | 20,042 | $ | 36,515 | $ | 127,567 | $ | 168,674 | |||||||
Repayments of line of credit | (24,633 | ) | (36,349 | ) | (142,118 | ) | (162,851 | ) | |||||||
Proceeds from borrowings | - | 2,284 | 1,000 | 36,617 | |||||||||||
Repayment of borrowings | (3,227 | ) | (2,192 | ) | (8,033 | ) | (6,081 | ) | |||||||
Repayment of related party loans | - | - | - | (1,200 | ) | ||||||||||
Principal payments on lease obligations | (3,227 | ) | (2,895 | ) | (12,162 | ) | (10,535 | ) | |||||||
Repayment private placement notes | - | - | - | (14,500 | ) | ||||||||||
Dividend distribution | - | (1,600 | ) | (121 | ) | (1,600 | ) | ||||||||
Payment of senior preferred shares | - | - | - | (5,972 | ) | ||||||||||
Net cash (outflow) / inflow from financing activities | $ | (11,045 | ) | $ | (4,237 | ) | $ | (33,867 | ) | $ | 2,552 | ||||
Effects of exchange rate difference on cash and cash equivalents | 18 | (60 | ) | (20 | ) | (316 | ) | ||||||||
Net increase / (decrease) in cash and cash equivalents | $ | 6,399 | $ | (4,564 | ) | $ | 12,997 | $ | (4,646 | ) | |||||
Cash and cash equivalents at beginning of the period | $ | 15,471 | $ | 13,437 | $ | 8,873 | $ | 13,519 | |||||||
Cash and cash equivalents at end of the period | $ | 21,870 | $ | 8,873 | $ | 21,870 | $ | 8,873 | |||||||
Unaudited Supplemental Non-GAAP Information
Reconciliation of Net Income from continuing operations to Adjusted EBITDA from continuing operations | ||||||||||||||||
Quarter ended |
Year ended |
|||||||||||||||
US$ in thousands | 2020 | 2019 | 2020 | 2019 | ||||||||||||
Net income / (loss) from continuing operations | $ | (3,805 | ) | $ | (4,647 | ) | $ | 7,770 | $ | (4,519 | ) | |||||
Finance expense | 2,238 | 2,251 | 9,428 | 7,709 | ||||||||||||
Income tax expense | 833 | 119 | 2,315 | 3,615 | ||||||||||||
Depreciation and amortization | 6,012 | 5,203 | 24,472 | 20,895 | ||||||||||||
EBITDA from continuing operations | $ | 5,278 | $ | 2,926 | $ | 43,985 | $ | 27,700 | ||||||||
Non-recurring expenses | 5,085 | 4,239 | 6,482 | 4,239 | ||||||||||||
Impairment | 777 | - | 777 | 163 | ||||||||||||
Other income | (227 | ) | (177 | ) | (745 | ) | (804 | ) | ||||||||
Fair value adjustment | 2,506 | 1 | 3,138 | (364 | ) | |||||||||||
Share-based payments | 478 | 48 | 359 | 4,087 | ||||||||||||
Foreign exchange (gain) / loss | (372 | ) | 349 | 151 | 1,274 | |||||||||||
Adjusted EBITDA from continuing operations | $ | 13,525 | $ | 7,386 | $ | 54,147 | $ | 36,295 | ||||||||
Reconciliation of Net income / (loss) from continuing operations to Adjusted net income / (loss) from continuing operations | ||||||||||||||||
Quarter ended |
Year ended |
|||||||||||||||
US$ in thousands | 2020 | 2019 | 2020 | 2019 | ||||||||||||
Net income / (loss) from continuing operations | $ | (3,805 | ) | $ | (4,647 | ) | $ | 7,770 | $ | (4,519 | ) | |||||
Non-recurring expenses | 5,085 | 4,239 | 6,482 | 4,239 | ||||||||||||
Impairment | 777 | - | 777 | 163 | ||||||||||||
Other income | (227 | ) | (177 | ) | (745 | ) | (804 | ) | ||||||||
Fair value adjustment | 2,506 | 1 | 3,138 | (364 | ) | |||||||||||
Share-based payments | 478 | 48 | 359 | 4,087 | ||||||||||||
Foreign exchange (gain) / loss | (372 | ) | 349 | 151 | 1,274 | |||||||||||
Total adjustments | $ | 8,247 | $ | 4,460 | $ | 10,162 | $ | 8,595 | ||||||||
Normalized tax rate* | 22.9 | % | 26.5 | % | 22.9 | % | 26.5 | % | ||||||||
Tax impact of adjustments | (1,889 | ) | (1,182 | ) | (2,327 | ) | (2,278 | ) | ||||||||
Adjusted net income / (loss) from continuing operations | $ | 2,553 | $ | (1,369 | ) | $ | 15,605 | $ | 1,798 | |||||||
* The 2019 tax rate has been adjusted to remove the impact of the cancellation of the legacy ESOP plan. | ||||||||||||||||
Calculation of pro forma adjusted earnings per share | ||||||||||||||
Quarter ended |
Year ended |
|||||||||||||
US$ in thousands | 2020 | 2019 | 2020 | 2019 | ||||||||||
Adjusted net income / (loss) from continuing operations | $ | 2,553 | $ | (1,369 | ) | $ | 15,605 | $ | 1,798 | |||||
Pro forma fully diluted shares* | 18,680,377 | 18,680,377 | 18,680,377 | 18,680,377 | ||||||||||
Pro forma adjusted earnings / (loss) per share | $ | 0.14 | $ | (0.07 | ) | $ | 0.84 | $ | 0.10 | |||||
* Pro forma fully diluted shares outstanding immediately following our initial public offering in |
Calculation of free cash flow | ||||||||
Year ended |
||||||||
US$ in thousands | 2020 | 2019 | ||||||
Net cash inflow from operating activities | $ | 51,719 | $ | 2,202 | ||||
Add: Impact of discontinued operations | - | 13,396 | ||||||
Less: | ||||||||
Capital expenditures | 16,917 | 9,707 | ||||||
Lease payments on right-of-use assets | 9,147 | 8,411 | ||||||
Free cash flow | $ | 25,655 | $ | (2,520 | ) | |||
Calculation of Net Debt | |||||||
US$ in thousands | |||||||
Borrowings | |||||||
Current | $ | 27,476 | $ | 41,835 | |||
Non-Current | 3,782 | 7,184 | |||||
$ | 31,258 | $ | 49,019 | ||||
Leases | |||||||
Current | 12,668 | 10,632 | |||||
Non-Current | 62,044 | 58,602 | |||||
$ | 74,712 | $ | 69,234 | ||||
Total Debt | $ | 105,970 | $ | 118,253 | |||
Cash | 21,870 | 8,873 | |||||
Net Debt | $ | 84,100 | $ | 109,380 | |||
Source: Ibex Limited